Affinity Asset Advisors, LLC

SEC CIK: 0001773195
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

CNTA holding history

Centessa Pharmaceuticals plc in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CNTA overview All 13F holders of CNTA Full Q2 2026 holdings

Shares (Q2 2026): 0; Sold out in Q2 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 19; Since Q2 2021

Holdings of CNTA by Affinity Asset Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	0	$0	0.0%	−1,400,000−100.0%	Sold out	Holders
Q1 2026	1,400,000	$55.6M	3.3%	+799,448+133.1%	Added	Holders
Q4 2025	600,552	$15.0M	1.1%	−506,610−45.8%	Reduced	Holders
Q3 2025	1,107,162	$26.8M	2.5%	+207,000+23.0%	Added	Holders
Q2 2025	900,162	$11.8M	1.7%	−646,500−41.8%	Reduced	Holders
Q1 2025	1,546,662	$22.2M	3.5%	+450,738+41.1%	Added	Holders
Q4 2024	1,095,924	$18.4M	2.9%	+130,312+13.5%	Added	Holders
Q3 2024	965,612	$15.4M	2.4%	−170,090−15.0%	Reduced	Holders
Q2 2024	1,135,702	$10.3M	1.6%	+305,156+36.7%	Added	Holders
Q1 2024	830,546	$9.39M	1.5%	+34,817+4.4%	Added	Holders
Q4 2023	795,729	$6.33M	1.3%	−222,362−21.8%	Reduced	Holders
Q3 2023	1,018,091	$6.59M	2.2%	+117,368+13.0%	Added	Holders
Q2 2023	900,723	$5.58M	2.2%	+216,596+31.7%	Added	Holders
Q1 2023	684,127	$2.63M	1.0%	+223,799+48.6%	Added	Holders
Q4 2022	460,328	$1.43M	0.7%	+217,811+89.8%	Added	Holders
Q3 2022	242,517	$975.0K	0.4%	+242,517	New	Holders
Q2 2022	0	$0	0.0%	−65,282−100.0%	Sold out	Holders
Q1 2022	65,282	$586.0K	0.2%	−353,862−84.4%	Reduced	Holders
Q4 2021	419,144	$4.72M	2.0%	+215,961+106.3%	Added	Holders
Q3 2021	203,183	$3.39M	1.4%	+136,226+203.5%	Added	Holders
Q2 2021	66,957	$1.49M	0.7%	+66,957	New	Holders